Mohsen Agharazii
Chercheur universitaire clinicien
Axe Endocrinologie et néphrologie
Néphrologie
Cardiologie et sciences circulatoires
Biologie vasculaire et endothéliale
Sciences cardiovasculaires cliniques et translationnelles
Publications
View all-
article Paré M, Zola N, Coudert L, Phaneuf JC, Lavallée R, Caplette-Gingras A, Fortier C, Agharazii M
A mixed-methods protocol to explore psychological distress and psychosocial needs along the continuum of CKD care- a single healthcare network
BMC Nephrol 26 (1), 2025.
-
article Desbiens LC, Veillette S, Fortier C, Nadeau-Fredette AC, Hametner B, Wassertheurer S, Madore F, Agharazii M, Goupil R
Prediction of cardiovascular events by algorithm- and formula-based pulse wave velocity
J Hypertens 44 (1), 2026.
-
article Ziasaeedi N, Lemaréchal Y, Agharazii M, Manem VSK, Després P, Ebrahimpour L
Radiomics-based kidney lesion classification: Mitigating batch effect with nested combat harmonization
Med Phys 52 (9), 2025.
Projects
- Mécanismes de la rigidité aortique en insuffisance rénale chez l'humain, from 2018-06-01 to 2026-04-30
- Towards a virtual cardiovascular system for understanding arterial stiffness and blood flow, from 2023-04-01 to 2028-03-31
- Blood pressure and vascular biomechanics: insights from numerical simulation models, from 2023-11-27 to 2026-04-30
- Sustainable Exercise Habits and Vascular Health in Hemodialysis Patients, from 2024-07-01 to 2026-06-30
- Taking advantage of the High Interindividual Heterogeneity in the Expression of HLA molecules on Human Kidney Endothelial Cells to Personalize Immunotherapy, from 2024-07-01 to 2026-06-30
- Développement d'une offre de soutien psychologique adaptée aux besoins des patients souffrants de maladies rénales chroniques au Québec, from 2024-09-01 to 2026-04-30
- NéphroPsy - Intégration de la santé psychologique au continuum de soins des patients en insuffisance rénale chronique: un modèle de pratique innovante en milieu hospitalier, from 2024-10-24 to 2026-11-01
- Comparer les mesures de pression artérielle à domicile faites à l’aide d’appareils validés et non validés à des mesures par monitoring ambulatoire, from 2025-08-13 to 2030-12-25
- A multicenter international randomized double-blind placebo-controlled clinical trial of the aldosterone synthase inhibitor BI 690517 in patients with chronic kidney disease treated with empagliflozin., from 2025-04-25 to 2031-12-25
- RENEW-HD --Sustaining Habits for Vascular Health, from 2025-07-01 to 2027-07-01
- REnin-guided TherApy with MinEralocorticoid receptor antagonists in Primary Aldosteronism - Feasibility study (RETAME-PA), from 2024-10-01 to 2027-09-30
- Subclinical Primary Aldosteronism: An Unrecognized, Modifiable Driver of Diastolic Heart Failure, from 2025-04-01 to 2028-03-31
- Néphro-psy - Besoins psychosociaux, détresse psychologique et perceptions de la rise en charge en insuffisance rénale chronique : étude mixte auprès des patients et du personnel, from 2025-06-11 to 2026-06-10
- Characterizing Cardiovascular Outcomes in Subclinical Primary Aldosteronism, from 2021-04-01 to 2026-03-31
- Arterial stiffness gradient as a new index of vascular aging: impact of blood pressure lowering medication, from 2019-10-01 to 2024-09-30
- Identifying low bone turnover disease in chronic kidney disease in order to guide anti-fracture therapy, from 2020-10-01 to 2025-09-30
- Early Prediction of preeclampsia Using arteriaL Stiffness in high-risk prEgnancies; a multinational study (PULSE), from 2020-04-01 to 2025-03-31
- Covid-19 effects on ARTErial StIffness and vascular AgiNg (CARTESIAN) study- Canada, from 2021-06-01 to 2025-03-31
- Characterizing Cardiovascular Outcomes in Subclinical Primary Aldosteronism, from 2021-04-01 to 2024-03-31
- Activités de réseautage de recherche en cardiologie, endocrinogie et néphrologie (CENNE), from 2022-05-01 to 2025-04-30
- Hydrochlorothiazide and accelerated CKD-related vascular calcification, from 2023-07-01 to 2025-06-30
- Transgenic rats overexpressing HDAC9 to explore the missing link between osteoporosis and vascular disease in chronic kidney disease, from 2023-06-21 to 2024-03-31
- Effet de contrôle glycémique sur la progression de la stéatose hépatique au sein du REGISTRE-NASH du CHU de Québec-Université Laval, from 2024-01-23 to 2024-12-31